Rigel Pharmaceuticals
XNAS: RIGL
Rigel Pharmaceuticals Live Stock Price Today, Share Analysis and Chart
about
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...
Read More
40.87
-0.47
(-1.14%)
841.1K
XNAS Volume
XNAS 08 Sep, 2025 5:30 PM (EDT)
Board Meeting
The board meeting for Rigel Pharmaceuticals is scheduled for today, for the purpose of H.C. Wainwright 27th Annual Global Investment Conference
See details
Not Eligible
Mid Valuation
Technically Bullish
Rigel Pharmaceuticals Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..